Buys
Open market- Shares
- Avg price
- Total value
R. Michael Carruthers - Chief Financial Officer at Edgewise Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- EWTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for R. Michael Carruthers in Edgewise Therapeutics, Inc.
Sells
Open market- Shares
- -1,428
- Avg price
- $13.39
- Total value
- -$19,124
Net
Past year- Shares
- -1,428
- Share %
- -100%
- Total value
- -$19,124
Reported holdings for R. Michael Carruthers in Edgewise Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Edgewise Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 86,162
- Estimated value
- $1,153,915
- Report date
- 12 Aug 2025
- Price
- $13.39
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Edgewise Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 26,875
- Estimated value
- $437,294
- Report date
- 12 Aug 2025
- Price
- $18.91
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Edgewise Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 161,250
- Estimated value
- Report date
- 12 Aug 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for R. Michael Carruthers in Edgewise Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.